Navigation Links
Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
Date:9/9/2008

are evaluating our lead MEK inhibitor, RDEA119, in a Phase 1 study in advanced cancer patients, and have completed a Phase 1 study in normal healthy volunteers as a precursor to trials in patients with inflammatory diseases. Lastly, we have evaluated our second-generation MEK inhibitor for the treatment of cancer and inflammatory diseases, RDEA436, in a human micro-dose pharmacokinetic study and have selected it for clinical development.

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding our goals, including the expected properties and benefits of RDEA806, RDEA427, RDEA594, RDEA119, RDEA436 and our other compounds and the results of preclinical, clinical and other studies. Risks that contribute to the uncertain nature of the

forward-looking statements include: risks related to the outcome of preclinical and clinical studies, risks related to regulatory approvals, delays in commencement of preclinical and clinical studies, and costs associated with our drug discovery and development programs and business development activities. These and other risks and uncertainties are described more fully in our most recently filed SEC documents, including our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q, under the headings "Risk Factors." All forward-looking statements contained in this press release speak only as of the date on which they were made. We undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.


'/>"/>
SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial
2. Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference
3. Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
4. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
5. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
6. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
7. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
8. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
9. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
10. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
11. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... CHARLOTTE, N.C. , Aug. 21, 2014 /PRNewswire-iReach/ ... Home Medical Equipment, Inc. for the third straight ... annual Inc. 500|5000, an exclusive ranking of the ... most comprehensive look at the most important segment ... Yelp, Pandora, Timberland, Dell, Domino,s Pizza, LinkedIn, Zillow, ...
(Date:8/21/2014)... 21, 2014 BreedIT Corp., ... the exclusive worldwide license holder and distributor of ... and researchers, today is pleased to announce the ... Seach Ltd, a leading Israeli medical Cannabis breeder. ... develop new breeds of medical Cannabis to meet ...
(Date:8/21/2014)... Aug. 21, 2014  AliveCor, Inc. announced ... Administration (FDA) has granted the company clearance ... (AFib), the most common form of cardiac ... detects if patients are experiencing AFib through ... mobile phone based AliveCor® Heart Monitor, so ...
Breaking Medicine Technology:Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4AliveCor Receives First FDA Clearance to Detect a Serious Heart Condition in an ECG on a Mobile Device 2
(Date:8/21/2014)... August 21, 2014 Pack Expo ... Packaging and Processing Technologies. They deliver the industry’s ... into a whole new world of advancement and ... interactive education, and the latest technology and innovations ... exhibitors. This year at Pack Expo International, 50,000 ...
(Date:8/21/2014)... 2014 Today, Zane Benefits, the #1 ... premium tax credits in 2015. , According to Zane ... of the Affordable Care Act (ACA), premium tax credits ... health insurance through the Health Insurance Marketplaces. , The ... the amount of the tax credits, updated for 2015. ...
(Date:8/21/2014)... support technology, the University of Michigan,s Transplant Center was ... pancreases available for transplant by about 20 percent. , ... and detail the impact of more than 10 ... improve the quality and viability of organs donated after ... by the number of donated organs available, so the ...
(Date:8/21/2014)... Md. (PRWEB) August 21, 2014 ... Houston with an Education Forum for PH patients ... , Who:    The Pulmonary Hypertension Association – ... to find ways to prevent and cure pulmonary ... that affects the functioning of the heart and ...
(Date:8/21/2014)... African American women born at a low or ... risk for developing type 2 diabetes. The findings, which ... part the higher occurrence of type 2 diabetes in ... low birth weight. , Researchers from Boston University,s Slone ... the Black Women,s Health Study over the course of ...
Breaking Medicine News(10 mins):Health News:Absolute I&D Provides Discounted Labor for Pack Expo Chicago 2Health News:Extracorporeal support can significantly increase number of organs for transplant 2Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 3Health News:Low birth weight linked to higher incidence of type 2 diabetes in African American women 2
... Shows Five Masimo Rad-57 Pulse CO-Oximeters(TM) Detected 83 Unsuspected ... UK Reported Annual CO PoisoningsIRVINE, Calif., Feb. 18 ... Pulse CO-Oximetry and Measure-Through Motion and Low-Perfusion pulse oximetry, ... UK House of Commons All Party Parliamentary Gas Safety ...
... Mass., Feb. 18 NeuroTherm(R) has introduced a revolutionary ... pain, S i mplicity lll. S i mplicity lll ... use in the treatment of pain associated with lumbar ... medical ailments in the world.(LOGO: http://www.newscom.com/cgi-bin/prnh/20090217/NE70925LOGO )"In my ...
... /PRNewswire-Asia-FirstCall/ -- China YCT International,Group Inc., (OTC Bulletin ... company engaged in the business of developing, manufacturing ... Shandong,Spring Pharmaceutical Co. Ltd, today announced its fiscal ... 31, 2008. , , Third ...
... The Quantum Group,Inc. (NYSE Amex: QGP ) ... on the President signing the American Recovery and Reinvestment ... allocates $19.2 billion to technology,and innovation for the healthcare ... it was publicly introduced. , ...
... CINCINNATI, Feb. 18 LCA-Vision Inc. (Nasdaq:, ... of Directors has elected Edgar,F. (Skip) Heizer, III ... Board of,Directors, bringing total Board membership to six, ... "Skip Heizer brings LCA-Vision extensive operational, legal, corporate,governance ...
... Bariatric Surgery Centers of Excellence to offer designees exclusive access ... surgery. , ... Portland, OR (PRWEB) ... specialized complication insurance coverage for elective surgery, today announced a ...
Cached Medicine News:Health News:United Kingdom House of Commons Safety Group Recommends Carbon Monoxide Screening by Pulse CO-Oximetry(TM) to Reduce Misdiagnosis and Prevent Deaths 2Health News:United Kingdom House of Commons Safety Group Recommends Carbon Monoxide Screening by Pulse CO-Oximetry(TM) to Reduce Misdiagnosis and Prevent Deaths 3Health News:United Kingdom House of Commons Safety Group Recommends Carbon Monoxide Screening by Pulse CO-Oximetry(TM) to Reduce Misdiagnosis and Prevent Deaths 4Health News:United Kingdom House of Commons Safety Group Recommends Carbon Monoxide Screening by Pulse CO-Oximetry(TM) to Reduce Misdiagnosis and Prevent Deaths 5Health News:United Kingdom House of Commons Safety Group Recommends Carbon Monoxide Screening by Pulse CO-Oximetry(TM) to Reduce Misdiagnosis and Prevent Deaths 6Health News:New Relief for Sufferers of Low Back Pain 2Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 2Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 3Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 4Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 5Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 6Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 7Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 8Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 9Health News:The Quantum Group Compliments Congress and President Obama on Signing of Stimulus Bill into Law 2Health News:The Quantum Group Compliments Congress and President Obama on Signing of Stimulus Bill into Law 3Health News:The Quantum Group Compliments Congress and President Obama on Signing of Stimulus Bill into Law 4Health News:LCA-Vision Announces Appointment of Edgar F. Heizer to Board of Directors 2Health News:BLIS™ Announces Alliance with Surgical Review Corporation to Offer Surgical Complication Insurance Coverage for Bariatric Surgery Center of Excellence Designees 2Health News:BLIS™ Announces Alliance with Surgical Review Corporation to Offer Surgical Complication Insurance Coverage for Bariatric Surgery Center of Excellence Designees 3
... Immune Complexes from patient serum or plasma, standards ... onto microtiter wells. After a washing step, ... binds to the Fc region of human IgG. ... is pipetted followed by a stopping step. ...
...
...
...
Medicine Products: